Durvalumab showed long and durable effects after chemoradiotherapy in stage III non-small cell lung cancer: results of the PACIFIC study.

ABSTRACT:

SUBMITTER: Uemura T 

PROVIDER: S-EPMC5949402 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature